Uncertainty in Surgical Supplies-A Cardinal Error (A): Decision-Making as a Crisis Unfolds Custom Case Solution & Analysis

Section 1: Evidence Brief

Financial Metrics

Cardinal Health annual revenue: 145.5 billion dollars.
Medical Segment revenue: 15.6 billion dollars.
Inventory affected: 9.1 million surgical gowns.
Estimated units already distributed to healthcare providers: 2.5 million gowns.
Surgical gown market position: Cardinal Health is one of the top three providers in the United States.

Operational Facts

Product Type: Level 3 surgical gowns designed for moderate risk fluid exposure.
Manufacturing Location: Contracted sterilization facility in China.
Breach: Sterilization occurred at an unapproved location that did not meet Cardinal Health quality standards.
Supply Chain: The affected gowns represent a significant percentage of the daily national supply for operating rooms.
Timeline: The quality issue was discovered in early January 2020.

Stakeholder Positions

Mike Kaufmann (CEO): Primary concern is the long term reputation of the firm and adherence to safety protocols.
Steve Mason (CEO Medical Segment): Faces the operational reality of hospital shortages and potential cancellation of thousands of surgeries.
Hospital Administrators: Require immediate clarity to manage surgical schedules and patient safety.
Food and Drug Administration (FDA): Expects transparent reporting and immediate remedial action regarding medical device safety.

Information Gaps

Exact contamination rate: The case does not specify if any gowns have actually failed or caused infections.
Competitor capacity: Availability of Level 3 gowns from Owens and Minor or Medline to fill the gap is not quantified.
Financial liability: Potential cost of litigation from hospitals for canceled procedures is not provided.

Section 2: Strategic Analysis

Core Strategic Question

How can Cardinal Health mitigate the risk of patient harm and brand collapse without triggering a nationwide surgical crisis through supply depletion?

Structural Analysis

Applying the Crisis Management Framework to the surgical supply chain reveals that the problem is not a product failure but a process failure. The sterilization breach at the unapproved Chinese site creates a binary risk profile. Even if the probability of contamination is low, the impact of a single surgical site infection is catastrophic for both the patient and the company.

The bargaining power of buyers is currently low due to high switching costs and limited immediate alternatives. However, the threat of regulatory intervention is high. Cardinal Health must prioritize regulatory compliance and patient safety to maintain its license to operate in the medical device sector.

Strategic Options

Option	Rationale	Trade-offs
Full Voluntary Recall	Eliminates the risk of patient infection and demonstrates total commitment to quality.	Causes immediate shortages and significant revenue loss.
Conditional Use Advisory	Allows hospitals to use inventory after their own risk assessment to avoid canceling surgeries.	Shifts liability to customers and damages brand trust.
Phased Replacement	Recalls inventory as new sterile stock becomes available.	Leaves potentially dangerous products in the field for weeks.

Preliminary Recommendation

Cardinal Health should execute an immediate voluntary recall of all 9.1 million affected gowns. The integrity of the sterile field is the fundamental value proposition of the Medical Segment. Any compromise on this standard is a terminal threat to the business model. Short term operational chaos is preferable to a long term loss of institutional trust.

Section 3: Implementation Roadmap

Critical Path

T-Minus 24 Hours: Finalize formal notification to the FDA and prepare a national press release.
Day 1: Launch a dedicated digital portal for customers to identify affected lot numbers and initiate returns.
Day 1 to 5: Reallocate all available Level 4 gown inventory to trauma centers and high acuity hospitals to minimize surgical disruptions.
Day 7: Activate alternative sterilization partners in North America to process raw inventory bypasses.

Key Constraints

Logistical Friction: Returning 2.5 million units from thousands of decentralized hospital storage rooms is a massive reverse logistics challenge.
Production Lag: The lead time to manufacture and sterilize replacement Level 3 gowns is approximately six to eight weeks.

Risk-Adjusted Implementation Strategy

The strategy focuses on transparency and substitution. Cardinal Health must provide daily updates to hospital supply chain leaders regarding replacement timelines. To manage the shortage, the company will offer credits for competitors products if Cardinal cannot fulfill the order, prioritizing the patient over the immediate sale. This approach preserves the customer relationship for the post-crisis period.

Section 4: Executive Review and BLUF

BLUF

Cardinal Health must recall all 9.1 million Level 3 surgical gowns immediately. The sterilization breach at the unapproved facility in China invalidates the safety profile of the product. While this will cause a temporary shortage in the United States healthcare system, the alternative of allowing potentially non-sterile equipment into operating rooms is unacceptable. The company will prioritize inventory reallocation and transparent communication to manage the supply gap. Financial losses are significant but recoverable; the loss of clinical trust is not.

Dangerous Assumption

The analysis assumes that competitors have the excess capacity to absorb the demand surge. If Medline and Owens and Minor are also at peak capacity, the national shortage will be more severe than anticipated, potentially leading to a public health emergency that invites aggressive federal oversight.

Unaddressed Risks

Regulatory Escalation: The FDA may not stop at a voluntary recall and could initiate an audit of all contract manufacturing sterilization processes, leading to wider product holds.
Labor Shortage: The effort required by hospital staff to sort and return 2.5 million gowns during a period of increasing clinical demand may lead to low compliance with the recall.

Unconsidered Alternative

The team did not fully explore the possibility of onsite re-sterilization. If hospitals have the capacity to re-sterilize these gowns using their own autoclaves or ethylene oxide chambers, the inventory could be salvaged without leaving the site. This would solve the logistics problem and the supply problem simultaneously, provided the gown material can withstand a second sterilization cycle.